Novo Nordisk (NVO) reacted higher from support area
|Novo Nordisk A/S (NVO), a healthcare company engages in the research, development, manufacture & marketing of the pharmaceutical products worldwide. It operates in two segments, Diabetes & Obesity care & Biopharm. It is based in Denmark, comes under Healthcare – Biotechnology sector & trades as “NVO” ticker at NYSE.
As mentioned in the previous article, it favors higher in V of (I) of ((III)) & expected to find support from the blue box area to resume higher as impulse. It reacted from the blue box area as expected & can see further upside in (3) of ((3)) of V. Any buyers from the blue box area, are now having risk free position.
NVO – Elliott Wave view from 5.29.2023
It placed wave ((II)) at $30.89 low in 2016 & resume higher in (I) of ((III)). It placed wave I at $58.37 high & II at $41.23 low as 0.618 Fibonacci retracement. Above there, it extended higher in third wave extension, which ended as III at $122.16 high & IV at $95.02 low. Currently, it favors higher in ((3)) of V of (I) & expect short term upside to continue.
NVO – Elliott Wave latest daily view
In wave V, it placed ((1)) at $172.97 high, in which, it placed (1) at $144.78 high, (2) at 131.17 low, (3) at 171.70 high, (4) at 163.73 low & (5) as ((1)) at 172.97 high. It was expected to find support between the blue box in $158.05 – $149.16 in which it ended ((2)) at $151.12 low. Above ((2)) low, it breaks above ((1)) high, calling for further upside in ((3)) of V. It placed (1) at $166.54 high & (2) at 155.91 low. Currently, it favors higher in 5 of (3) before correcting in (4) of ((3)). It expects to remain supported in next 3, 7 or 11 swings pullback to see more upside. Alternatively, if it erases the momentum divergence in weekly, then it will be the part of III sequence in (I).
NVO – Elliott Wave latest weekly view
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.